{"doi":"10.1101/2020.05.04.20090407","title":"The genetic analysis of a founder Northern American population of European descent identifies <i>FANCI</i> as a candidate familial ovarian cancer risk gene","abstract":"Abstract Some familial ovarian cancer (OC) could be due to rare risk alleles in genes that each account for a relatively small proportion of cases not due to BRCA1 and BRCA2 , major risk genes in the homologous recombination (HR) DNA repair pathway. We report a new candidate OC risk allele, FANCI c.1813C&gt;T in a Fanconi anemia (FA) gene that plays a role upstream of the HR DNA repair pathway. This variant was identified by whole exome sequencing of a BRCA1 and BRCA2 mutation-negative French Canadian (FC) OC family from a population exhibiting founder effects. In FCs, the c.1813C&gt;T allele was detected in 7% (3/43) of familial and 1.6% (7/439) of sporadic OC cases; and in 3.7% (3/82) of familial breast cancer (BC) cases with a family history of OC and in 1.9% (3/158) of BC only families. This allele was significantly associated with FC BRCA1 and BRCA2 mutation-negative OC families (OR=5.6; 95%CI=1.6-19; p=0.006). Although FANCI c.1813C&gt;T was detected in 2.5% (74/2950) of cancer-free FC females, carriers had a personal history of known OC risk reducing factors, and female/male carriers were more likely to have reported a first-degree relative with OC (ρ=0.037; p=0.011). Eight rare potentially pathogenic FANCI variants were identified in 3.3% (17/516) of Australian OC cases, including 10 carriers of FANCI c.1813C&gt;T. Potentially pathogenic FANCI variants were significantly more common in AUS OC cases with a family history of OC than in isolated OC cases (p=0.027). The odds ratios (OR) were &gt;3 for carriers of any of the seven rarest FANCI alleles, and 1.5 for c.1813C&gt;T. Data from the OC Association Consortium revealed that the ORs for the c.1813C&gt;T allele were highest for the most common OC subtypes. Localization of FANCD2, part of the FANCI-FANCD2 (ID2) binding complex in the FA pathway, to sites of induced DNA damage was severely impeded in cells expressing the p.L605F isoform. This isoform was expressed at a reduced level; unstable by formaldehyde or mitomycin C treatment; and exhibited sensitivity to cisplatin but not to olaparib (a poly [ADP-ribose] polymerase inhibitor). By tissue microarray analyses, FANCI protein was robustly expressed in fallopian tube epithelial cells but expressed at low-to-moderate levels in 88% (83/94) of high-grade serous carcinoma OC samples. This is the first study to describe potentially pathogenic variants in OC in a member of the ID2 complex of the FA DNA repair pathway. Our data suggest that potentially pathogenic FANCI variants may modify OC risk in cancer families.","journal":"medRxiv","year":2020,"id":124854,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9535,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":570083,"name":"Laure Guitton-Sert","orcid":"0000-0002-4529-5493","position":1,"is_corresponding":false},{"id":570084,"name":"Wejdan M. Alenezi","orcid":"0000-0002-2882-7267","position":2,"is_corresponding":false},{"id":570085,"name":"Timothée Revil","orcid":"0000-0003-1210-7748","position":3,"is_corresponding":false},{"id":570570,"name":"Kathleen Klein Oros","orcid":null,"position":4,"is_corresponding":false},{"id":570086,"name":"Karine Bédard","orcid":"0000-0003-4258-8319","position":5,"is_corresponding":false},{"id":570571,"name":"Suzanna L. Arcand","orcid":null,"position":6,"is_corresponding":false},{"id":570572,"name":"Corinne Serruya","orcid":null,"position":7,"is_corresponding":false},{"id":570087,"name":"Supriya Behl","orcid":"0000-0002-6672-4824","position":8,"is_corresponding":false},{"id":570088,"name":"Liliane Meunier","orcid":"0000-0001-6795-6646","position":9,"is_corresponding":false},{"id":570573,"name":"Hubert Fleury","orcid":null,"position":10,"is_corresponding":false},{"id":264373,"name":"Eleanor Fewings","orcid":"0000-0001-9012-3220","position":11,"is_corresponding":false},{"id":570089,"name":"Deepak Subramanian","orcid":"0000-0002-0891-9324","position":12,"is_corresponding":false},{"id":570090,"name":"Javad Nadaf","orcid":"0000-0001-9393-810X","position":13,"is_corresponding":false},{"id":22220,"name":"Diane Provencher","orcid":"0000-0003-1902-3256","position":14,"is_corresponding":false},{"id":70648,"name":"William D. Foulkes","orcid":"0000-0001-7427-4651","position":15,"is_corresponding":false},{"id":570091,"name":"Zaki El Haffaf","orcid":"0000-0001-5756-6329","position":16,"is_corresponding":false},{"id":22235,"name":"Anne‐Marie Mes‐Masson","orcid":"0000-0002-6498-266X","position":17,"is_corresponding":false},{"id":70645,"name":"Jacek Majewski","orcid":"0000-0003-3572-9558","position":18,"is_corresponding":false},{"id":254475,"name":"Marc Tischkowitz","orcid":"0000-0002-7880-0628","position":19,"is_corresponding":false},{"id":254676,"name":"Paul A. James","orcid":"0000-0002-4361-4657","position":20,"is_corresponding":false},{"id":249328,"name":"Ian Campbell","orcid":"0000-0002-7773-4155","position":21,"is_corresponding":false},{"id":304553,"name":"Celia M.T. Greenwood","orcid":"0000-0002-2427-5696","position":22,"is_corresponding":false},{"id":40170,"name":"Jiannis Ragoussis","orcid":"0000-0002-8515-0934","position":23,"is_corresponding":false},{"id":570092,"name":"Jean‐Yves Masson","orcid":"0000-0002-4403-7169","position":24,"is_corresponding":false},{"id":22219,"name":"Patricia N. Tonin","orcid":null,"position":25,"is_corresponding":false},{"id":570082,"name":"Caitlin T. Fierheller","orcid":"0000-0001-9583-3061","position":0,"is_corresponding":true}],"reference_count":140,"raw_metadata":null,"created_at":"2026-07-18T23:15:11.632153Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}